These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19629166)

  • 21. Dominant resistance and negative epistasis can limit the co-selection of de novo resistance mutations and antibiotic resistance genes.
    Porse A; Jahn LJ; Ellabaan MMH; Sommer MOA
    Nat Commun; 2020 Mar; 11(1):1199. PubMed ID: 32139686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epistasis between new mutations and genetic background and a test of genetic canalization.
    Elena SF; Lenski RE
    Evolution; 2001 Sep; 55(9):1746-52. PubMed ID: 11681730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of multiple drug resistance in Pseudomonas aeruginosa.
    Ward H; Perron GG; Maclean RC
    J Evol Biol; 2009 May; 22(5):997-1003. PubMed ID: 19298493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pervasive joint influence of epistasis and plasticity on mutational effects in Escherichia coli.
    Remold SK; Lenski RE
    Nat Genet; 2004 Apr; 36(4):423-6. PubMed ID: 15072075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost of antibiotic resistance and the geometry of adaptation.
    Sousa A; Magalhães S; Gordo I
    Mol Biol Evol; 2012 May; 29(5):1417-28. PubMed ID: 22144641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiosyncratic variation in the fitness costs of tetracycline-resistance mutations in Escherichia coli.
    Card KJ; Jordan JA; Lenski RE
    Evolution; 2021 May; 75(5):1230-1238. PubMed ID: 33634468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental changes bridge evolutionary valleys.
    Steinberg B; Ostermeier M
    Sci Adv; 2016 Jan; 2(1):e1500921. PubMed ID: 26844293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteostasis Environment Shapes Higher-Order Epistasis Operating on Antibiotic Resistance.
    Guerrero RF; Scarpino SV; Rodrigues JV; Hartl DL; Ogbunugafor CB
    Genetics; 2019 Jun; 212(2):565-575. PubMed ID: 31015194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of macroscopic epistasis on long-term evolutionary dynamics.
    Good BH; Desai MM
    Genetics; 2015 Jan; 199(1):177-90. PubMed ID: 25395665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The consistency of beneficial fitness effects of mutations across diverse genetic backgrounds.
    Pearson VM; Miller CR; Rokyta DR
    PLoS One; 2012; 7(8):e43864. PubMed ID: 22937113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rates of fitness decline and rebound suggest pervasive epistasis.
    Perfeito L; Sousa A; Bataillon T; Gordo I
    Evolution; 2014 Jan; 68(1):150-62. PubMed ID: 24372601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epistasis buffers the fitness effects of rifampicin- resistance mutations in Pseudomonas aeruginosa.
    Hall AR; MacLean RC
    Evolution; 2011 Aug; 65(8):2370-9. PubMed ID: 21790582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic evolution of antibiotic resistance is contingent on genetic background following a long-term experiment with
    Card KJ; Thomas MD; Graves JL; Barrick JE; Lenski RE
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33441451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environment changes epistasis to alter trade-offs along alternative evolutionary paths.
    Hall AE; Karkare K; Cooper VS; Bank C; Cooper TF; Moore FB
    Evolution; 2019 Oct; 73(10):2094-2105. PubMed ID: 31418459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain.
    Olson CA; Wu NC; Sun R
    Curr Biol; 2014 Nov; 24(22):2643-51. PubMed ID: 25455030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection biases the prevalence and type of epistasis along adaptive trajectories.
    Draghi JA; Plotkin JB
    Evolution; 2013 Nov; 67(11):3120-31. PubMed ID: 24151997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of epistatic interactions and fitness landscapes using a new geometric approach.
    Beerenwinkel N; Pachter L; Sturmfels B; Elena SF; Lenski RE
    BMC Evol Biol; 2007 Apr; 7():60. PubMed ID: 17433106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression profiles reveal parallel evolution of epistatic interactions involving the CRP regulon in Escherichia coli.
    Cooper TF; Remold SK; Lenski RE; Schneider D
    PLoS Genet; 2008 Feb; 4(2):e35. PubMed ID: 18282111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131.
    Ben Zakour NL; Alsheikh-Hussain AS; Ashcroft MM; Khanh Nhu NT; Roberts LW; Stanton-Cook M; Schembri MA; Beatson SA
    mBio; 2016 Apr; 7(2):e00347-16. PubMed ID: 27118589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.